Illumina Jan 23, 2026 Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Illumina Jan 23, 2026 Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Illumina Jan 23, 2026 Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat
Illumina Jan 23, 2026 Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Jan 23, 2026 $4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore
Illumina Jan 22, 2026 Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st
Illumina Jan 22, 2026 Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Illumina Jan 21, 2026 Illumina (NASDAQ:ILMN) Sets New 52-Week High - Here's What Happened - MarketBeat
Illumina Jan 20, 2026 Optimizing Illumina Long-Read Whole Genome Sequencing of Salivary DNA Using Oragene™ Collection Devices - the-scientist.com
Illumina Jan 20, 2026 Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq
Illumina Jan 20, 2026 Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire
Illumina Jan 20, 2026 Stifel raises Illumina stock price target to $155 on growth outlook - Investing.com